We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

15 hedge funds and large institutions have $513K invested in InVivo Therapeutics Holdings Corp in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 16 → 15 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

52% less capital invested

Capital invested by funds: $1.07M → $513K (-$555K)

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$65.9K
2
WS
Wedbush Securities
California
+$19.3K
3
Citadel Advisors
Citadel Advisors
Florida
+$13.2K
4
Deutsche Bank
Deutsche Bank
Germany
+$5.27K

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$116K
2
MAM
Meeder Asset Management
Ohio
-$7K
3
UBS Group
UBS Group
Switzerland
-$5.27K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$324K +$65.9K +75 +15%
Vanguard Group
2
Vanguard Group
Pennsylvania
$64K – – –
Citadel Advisors
3
Citadel Advisors
Florida
$24K +$13.2K +15 +54%
ICM
4
IMS Capital Management
Oregon
$22K – – –
BCM
5
Bridgeway Capital Management
Texas
$19K – – –
BlackRock
6
BlackRock
New York
$14K – – –
WS
7
Wedbush Securities
California
$12K +$19.3K +22 New
Northern Trust
8
Northern Trust
Illinois
$11K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$7K – – –
PWM
10
Paulson Wealth Management
Illinois
$7K – – –
Morgan Stanley
11
Morgan Stanley
New York
$4K – – –
Deutsche Bank
12
Deutsche Bank
Germany
$3K +$5.27K +6 New
AG
13
Advisor Group
Arizona
$1K – – –
NCM
14
Next Capital Management
New York
$1K – – –
BNP Paribas Financial Markets
15
BNP Paribas Financial Markets
France
$1 – – –
CH
16
CVI Holdings
Delaware
– -$116K -99 Closed
MAM
17
Meeder Asset Management
Ohio
– -$7K -6 Closed
UBS Group
18
UBS Group
Switzerland
– -$5.27K -6 Closed

NVIV Hedge Fund Activity: Q2 2019 in Review

15 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q2 2019, worth a combined $513K — down 52% from $1.07M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NVIV and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was Renaissance Technologies, adding an estimated $65.9K. The largest seller was CVI Holdings, exiting entirely with an estimated $116K sold.

  • 15 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q2 2019, down from 16 in Q1 2019.
  • Funds reported $513K of InVivo Therapeutics Holdings Corp stock for Q2 2019, down 52% quarter-over-quarter.
  • 2 funds opened new InVivo Therapeutics Holdings Corp positions in Q2 2019 and 3 closed out, a net change of -1 holder.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q2 2019 was Renaissance Technologies, an estimated $65.9K added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q2 2019 was CVI Holdings, an estimated $116K sold.

Based on aggregated 13F filings for Q2 2019.